Document Detail

Maintaining a minimally invasive approach-vascular closure after trans-catheter aortic valve intervention.
MedLine Citation:
PMID:  23242973     Owner:  NLM     Status:  Publisher    
Trans-catheter aortic valve implantation (TAVI) is now recognised as an effective way to treat patients with symptomatic aortic stenosis when open surgical repair is not feasible or considered too high risk. Retrograde trans-femoral TAVI (TF-TAVI) requires large bore vascular access (18-24F), and successful management of the access site is key to maintaining the minimally invasive nature of the procedure. This editorial reviews the current techniques available to facilitate percutaneous vascular closure and the common complications associated with vascular access.
James Cockburn; Adam de Belder; Mike Lewis; Uday Trivedi; David Hildick-Smith
Related Documents :
24427433 - Death after closed adolescent knee injury and popliteal artery occlusion: a case report...
22623003 - Coronary artery stenting in a patient with factor xi deficiency.
24318613 - Divergent determinants of (18)f-naf uptake and visible calcium deposition in large arte...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-15
Journal Detail:
Title:  Journal of thrombosis and thrombolysis     Volume:  -     ISSN:  1573-742X     ISO Abbreviation:  J. Thromb. Thrombolysis     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9502018     Medline TA:  J Thromb Thrombolysis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Sussex Cardiac Centre, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK,
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The comparison of EPC count and function in the situation of vascular repair at early and late stage...
Next Document:  Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their...